Showing results (1-10 of 42,272) with videos related to
Sort By:
Pageof 4,228
Immunotherapy|January 5, 2019
Progressive diffuse large B-cell lymphoma with TP53 gene mutation treated with chidamide-based chemotherapyQing Li, Jingcao Huang, Yang Ou, et al.Zhongguo Shi Yan Xue Ye Xue Za Zhi|June 18, 2019
[Role of Pim1 Gene Overexpression in Pathogenesis of Acute Myeloid Leukemia]Qing Li, Rui-Xue Sun, Yang Ou, et al.Clinical Endocrinology|October 15, 2025
Environmental Endocrine-Disrupting Chemicals, Pancreatic β-Cells, and Type 2 Diabetes MellitusYan-Li Zhao, Yang OuOncotargets and Therapy|August 9, 2020
PIM3 Promotes the Proliferation and Migration of Acute Myeloid Leukemia CellsHongmei Luo, Ruixue Sun, Yuhuan Zheng, et al.Endocrine Research|October 21, 2024
Pancreatic β-Cells, Diabetes and AutophagyYang Ou, Yan-Li Zhao, Heng SuCytokine|September 8, 2019
Relationship between the IL-10 (-1082 A/G) polymorphism and the risk of immune/idiopathic thrombocytopenic purpura: A meta-analysisYang Ou, Yan Yang, Xinrong Xiang, et al.Cell Death & Disease|August 8, 2025
Chidamide and cytarabine synergistically treat acute myeloid leukemia: inhibiting ribosome biogenesis via the MYC-RRP9 pathwayQing Li, Fangfang Wang, Xinrong Xiang, et al.Frontiers in Oncology|March 12, 2026
Chidamide combined with decitabine, venetoclax, and low-dose cytarabine for relapsed/refractory acute myeloid leukemia: a single-center case seriesQing Li, Jie Ji, Yu WuScience China. Life Sciences|January 11, 2018
Epigenetic mechanism of survivin dysregulation in human cancerHui Lyu, Jingcao Huang, Zhimin He, et al.Frontiers in Pharmacology|December 21, 2020
Efficacy and Safety of CAR-Modified T Cell Therapy in Patients with Relapsed or Refractory Multiple Myeloma: A Meta-Analysis of Prospective Clinical TrialsXinrong Xiang, Qiao He, Yang Ou, et al.Pageof 4,228